Belgium· BE-AMP-SAM370815-00

Periolimel N4E

A lösungen zur parenteralen ernährung, kombinationen product containing sodium glycerophosphate hydrate, registered in Belgium by Baxter. The same ATC class is registered in 11 of our 19 countries.

ATC B05BA10

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about sodium glycerophosphate hydrateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Lösungen zur parenteralen ernährung, kombinationen is registered in 11 of 19 countries.

Countries holding a registration under ATC B05BA10 (lösungen zur parenteralen ernährung, kombinationen), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
7 of them publish a price we can compare per daily dose

Search lösungen zur parenteralen ernährung, kombinationen products by name

Lösungen zur parenteralen ernährung, kombinationen · ATC B05BA10

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Sodium Glycerophosphate Hydrate
Manufacturer: Baxter
Country: Belgium (BE)
ATC code: B05BA10
ATC class: Lösungen zur parenteralen Ernährung, Kombinationen
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 8

be_apb
2786200
be_apb
0758573
be_apb
2786218
be_apb
0758565
be_apb
2786226
be_apb
0758557
be_apb
2786234
be_apb
0758540

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

6 interactions on record for lösungen zur parenteralen ernährung, kombinationen.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check lösungen zur parenteralen ernährung, kombinationen against other medicines How interaction checks work

Lösungen zur parenteralen ernährung, kombinationen · interactions on record

6 records

2 severe
4 moderate

Most severe, free to view

ErdafitinibL01EN01severe
ErdafitinibL01EX16severe
AmfetamineN06BA01moderate
DexamfetamineN06BA02moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lösungen zur parenteralen ernährung, kombinationen in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lösungen zur parenteralen ernährung, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

Austria · Glycophos
Cyprus · Glycophos
Czechia · Sodium Glycerophosphate Fresenius
Germany · Natriumglycerophosphat-Ampulle Fresenius
Denmark · Glycophos
Spain · Glycophos
Finland · Glycophos
France · Glycerophosphate De Sodium
Greece · Glycophos
Hungary · Nátrium-Glicerin-Foszfát Fresenius
Italy · Glycophos
Lithuania · Glycophos
Latvia · Glycophos
Netherlands · Glycophos
Poland · Glycophos
Portugal · Glycophos
Romania · Glycophos
Sweden · Glycophos
Slovakia · Sodium Glycerophosphate Fresenius

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/13610f81-fbb8-44c7-8593-ccc31a4a7f58
GET /v1/drugs/13610f81-fbb8-44c7-8593-ccc31a4a7f58?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Emulsion for infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Periolimel N4E",
  "name_fr": "Periolimel N4E",
  "name_nl": "Periolimel N4E",
  "amp_code": "SAM370815-00",
  "strengths": [
    "1.9100",
    "0.0600",
    "1.6200",
    "1.7600",
    "1.1600",
    "1.2600",
    "1.5100",
    "0.3000",
    "1.2600",
    "1.0000",
    "2.5300",
    "82.5000"
  ],
  "pack_count": 11,
  "substances": [
    "Sodium Glycerophosphate Hydrate",
    "Sodium Glycerophosphate",
    "Tyrosine",
    "Valine",
    "Phenylalanine",
    "Sodium Acetate Trihydrate",
    "Isoleucine",
    "Histidine",
    "Calcium Chloride Dihydrate",
    "Threonine",
    "Serine",
    "Arginine",
    "Glucose Monohydrate",
    "Glucose Anhydrous",
    "Methionine",
    "Soyabean Oil + Olive Oil",
    "Lysine Acetate",
    "Lysine",
    "Glutamic Acid",
    "Alanine",
    "Leucine",
    "Tryptophan",
    "Aspartic Acid",
    "Proline",
    "Glycine",
    "Potassium Chloride",
    "Magnesium Chloride Hexahydrate",
    "Glycerol",
    "Sodium Hydroxide",
    "Sodium Oleate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Combinations",
  "authorisation_numbers": [
    "BE370815",
    "BE370824",
    "BE370833",
    "BE370842"
  ]
}

API reference MCP server Plans

See everything about lösungen zur parenteralen ernährung, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console